Related Experiment Videos
Platelet function in blood from the coronary sinus in patients with arteriosclerotic heart disease
Insights
Platelet function, including aggregation and retention, is reduced in the coronary sinus blood of men with heart disease. This reduced platelet activity is not solely mediated by prostaglandins, suggesting other mechanisms in the coronary circulation.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Platelet Physiology
Background:
- Platelet function is crucial in cardiovascular health and disease.
- Coronary heart disease (CHD) may involve altered platelet behavior within the coronary circulation.
Purpose of the Study:
- To compare platelet function in coronary sinus blood versus superior caval vein blood in men with CHD.
- To investigate the mechanisms underlying potential differences in platelet function.
Main Methods:
- Blood samples were collected simultaneously from the coronary sinus and superior caval vein in 50 men with CHD.
- Platelet aggregation (ADP- and collagen-induced) and platelet retention were measured.
- Plasma beta-thromboglobulin, platelet counts, and circulating platelet aggregates were assessed.
Main Results:
- Coronary sinus blood showed reduced ADP-induced aggregation (14%), collagen-induced aggregation (10%), and platelet retention (16-30%) compared to caval vein blood.
- Plasma beta-thromboglobulin, platelet counts, and circulating platelet aggregates were similar between the two sample sites.
- Selective thromboxane synthetase inhibitor (Dazoxiben) and acetylsalicylic acid normalized aggregation but not retention in coronary sinus blood.
Conclusions:
- Platelet function is significantly reduced in the coronary sinus of men with CHD.
- This reduction is not due to platelet refractoriness or increased aggregation.
- The findings suggest a direct depressive effect on platelet function within the coronary circulation, not solely mediated by prostaglandins.
Abstract:
Blood sampled from the coronary sinus was compared with blood collected simultaneously from the superior caval vein in 50 men with angiographically proven coronary heart disease. Primary, ADP-induced aggregation in coronary sinus blood was reduced by 14 per cent, collagen-induced aggregation by 10 and platelet retention by 16 to 30 per cent as compared with blood from the caval vein. The plasma levels of beta-thromboglobulin, platelet counts and number of circulating platelet aggregates were similar in parallel samples. The reduced platelet function in coronary sinus blood hardly reflects refractoriness after previous platelet stimulation, since no release or irreversible aggregation was induced. A reduced function might be the effect of direct depression induced in the coronary circulation. Most surprisingly, a selective thromboxane synthetase inhibitor (Dazoxiben) and acetylsalicylic acid normalized platelet aggregation but did not affect the low platelet retention response in coronary sinus blood. Thus, the reduced platelet function in coronary sinus blood is not only mediated via prostaglandins.